Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 219
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
James Maksymetz, Sean P. Moran, P. Jeffrey Conn
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Branched Photoswitchable Tethered Ligands Enable Ultra-efficient Optical Control and Detection of G Protein-Coupled Receptors In Vivo
Amanda Acosta-Ruiz, Vanessa A. Gutzeit, Mary Jane Skelly, et al.
Neuron (2019) Vol. 105, Iss. 3, pp. 446-463.e13
Open Access | Times Cited: 81
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Melissa A. Snyder, Wen‐Jun Gao
Schizophrenia Research (2019) Vol. 217, pp. 60-70
Open Access | Times Cited: 80
Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 70
Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia
Shalini Dogra, P. Jeffrey Conn
Molecular Pharmacology (2022) Vol. 101, Iss. 5, pp. 275-285
Open Access | Times Cited: 62
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research
Maria R. Dauvermann, Graham Lee, Neil Dawson
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3136-3160
Open Access | Times Cited: 78
International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors
Karen J. Gregory, Cyril Goudet
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 521-569
Open Access | Times Cited: 53
Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
Si Han Li, Khaled S. Abd‐Elrahman, Stephen S. G. Ferguson
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108275-108275
Closed Access | Times Cited: 32
The role of glutamate receptors in attention‐deficit/hyperactivity disorder: From physiology to disease
Xin Huang, Min Wang, Qi Zhang, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2019) Vol. 180, Iss. 4, pp. 272-286
Closed Access | Times Cited: 48
Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors
Branden J. Stansley, P. Jeffrey Conn
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 4, pp. 240-252
Open Access | Times Cited: 41
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease
Deborah J. Luessen, P. Jeffrey Conn
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 630-661
Open Access | Times Cited: 22
Impairments in the early consolidation of spatial memories via group II mGluR agonism in the mammillary bodies
Michal M. Milczarek, James C. Perry, Eman Amin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Clinton E. Canal
Handbook of experimental pharmacology (2018), pp. 227-260
Open Access | Times Cited: 33
Zebrafish models for studying cognitive enhancers
Tatiana O. Kolesnikova, Konstantin A. Demin, Fabiano V. Costa, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105797-105797
Closed Access | Times Cited: 3
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
Irene Fasciani, Francesco Petragnano, Gabriella Aloisi, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 388-388
Open Access | Times Cited: 21
Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
Mark J. Benvenga, Stephen F. Chaney, Melvyn Baez, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 23
Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice
Carla L. Busceti, Luisa Di Menna, Sonia Castaldi, et al.
eNeuro (2024) Vol. 11, Iss. 8, pp. ENEURO.0523-23.2024
Open Access | Times Cited: 2
Auditory verbal hallucination and the auditory network: From molecules to connectivity
Jianjie Huang, Chuanjun Zhuo, Yong Xu, et al.
Neuroscience (2019) Vol. 410, pp. 59-67
Closed Access | Times Cited: 18
Beyond NMDA Receptors: Homeostasis at the Glutamate Tripartite Synapse and Its Contributions to Cognitive Dysfunction in Schizophrenia
Hagar Bauminger, Inna Gaisler‐Salomon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8617-8617
Open Access | Times Cited: 11
Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801
Peter U. Hámor, Jana Šírová, Tomáš Páleníček, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 175, pp. 89-100
Open Access | Times Cited: 18
Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia
Daniel H. Wolf, David Zheng, Christian G. Kohler, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1226-1232
Open Access | Times Cited: 14
How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
Salar Vaseghi, Mohammad Nasehi, Mohammad‐Reza Zarrindast
Neuroscience & Biobehavioral Reviews (2020) Vol. 120, pp. 173-221
Closed Access | Times Cited: 14
Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice
Carla L. Busceti, Roxana Paula Ginerete, Luisa Di Menna, et al.
Neuropharmacology (2021) Vol. 196, pp. 108692-108692
Closed Access | Times Cited: 12
Phenotypic landscape of schizophrenia-associated genes defines candidates and their shared functions
Summer B. Thyme, Lindsey M. Pieper, Eric H. Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top